Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Narendra Kumar

Showing results (841-850 of 878) with videos related to

Pageof 88
Sort By:
International Journal of Rheumatic Diseases|April 13, 2026
Management of Polyarticular Course Juvenile Idiopathic Arthritis and Temporomandibular Joint Arthritis: A Systematic Literature Review and Meta-Analysis Informing the APLAR Consensus RecommendationsKai Liang Teh, Mariel B Valmonte, Taqdees Khaliq, et al.
Bulletin of the World Health Organization|December 2, 2025
Target product profiles for paediatric formulations of azithromycin and nitrofurantoinYasir Bin Nisar, Giulia Brigadoi, Shabina Ariff, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 2, 2016
Surgical ablation in patients undergoing mitral valve surgery: impact of lesion set and surgical techniques on long-term successSandro Gelsomino, Mark La Meir, Henrica N A M Van Breugel, et al.
Trials|July 5, 2024
Role of central endpoint adjudication and challenges in trials on neonatal sepsis-a case of ProSPoNS trialAnju Pradhan Sinha, Dilip Raja, Kamlesh S Mahajan, et al.
Neurosurgery|November 7, 2024
Long-Term Outcomes of Stereotactic Radiosurgery for Pineocytomas: An International Multicenter StudyAndréanne Hamel, Jean-Nicolas Tourigny, Ajay Niranjan, et al.
Journal of Medicinal Chemistry|May 29, 2014
The discovery of Polo-like kinase 4 inhibitors: design and optimization of spiro[cyclopropane-1,3'[3H]indol]-2'(1'H).ones as orally bioavailable antitumor agentsPeter B Sampson, Yong Liu, Narendra Kumar Patel, et al.
Bipolar Disorders|December 28, 2020
Endoxifen: A new, protein kinase C inhibitor to treat acute and mixed mania associated with bipolar I disorderAteeq Ahmad, Saifuddin Sheikh, Mujtaba Ali Khan, et al.
Discover Oncology|June 21, 2026
Bevacizumab added to conventional induction chemotherapy for children with high risk neuroblastoma (BRAVEN trial)Jagdish Prasad Meena, Debasish Sahoo, Harshita Makkar, et al.
Nano Letters|November 9, 2020
Modulation Doping via a Two-Dimensional Atomic Crystalline AcceptorYiping Wang, Jesse Balgley, Eli Gerber, et al.
Journal of Medicinal Chemistry|February 28, 2015
The discovery of Polo-like kinase 4 inhibitors: identification of (1R,2S).2-(3-((E).4-(((cis).2,6-dimethylmorpholino)methyl)styryl). 1H.indazol-6-yl)-5'-methoxyspiro[cyclopropane-1,3'-indolin]-2'-one (CFI-400945) as a potent, orally active antitumor agentPeter B Sampson, Yong Liu, Bryan Forrest, et al.
Pageof 88

Showing results (841-850 of 878) with videos related to

Sort By:
Pageof 88
International Journal of Rheumatic Diseases|April 13, 2026
Management of Polyarticular Course Juvenile Idiopathic Arthritis and Temporomandibular Joint Arthritis: A Systematic Literature Review and Meta-Analysis Informing the APLAR Consensus RecommendationsKai Liang Teh, Mariel B Valmonte, Taqdees Khaliq, et al.
Bulletin of the World Health Organization|December 2, 2025
Target product profiles for paediatric formulations of azithromycin and nitrofurantoinYasir Bin Nisar, Giulia Brigadoi, Shabina Ariff, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 2, 2016
Surgical ablation in patients undergoing mitral valve surgery: impact of lesion set and surgical techniques on long-term successSandro Gelsomino, Mark La Meir, Henrica N A M Van Breugel, et al.
Trials|July 5, 2024
Role of central endpoint adjudication and challenges in trials on neonatal sepsis-a case of ProSPoNS trialAnju Pradhan Sinha, Dilip Raja, Kamlesh S Mahajan, et al.
Neurosurgery|November 7, 2024
Long-Term Outcomes of Stereotactic Radiosurgery for Pineocytomas: An International Multicenter StudyAndréanne Hamel, Jean-Nicolas Tourigny, Ajay Niranjan, et al.
Journal of Medicinal Chemistry|May 29, 2014
The discovery of Polo-like kinase 4 inhibitors: design and optimization of spiro[cyclopropane-1,3'[3H]indol]-2'(1'H).ones as orally bioavailable antitumor agentsPeter B Sampson, Yong Liu, Narendra Kumar Patel, et al.
Bipolar Disorders|December 28, 2020
Endoxifen: A new, protein kinase C inhibitor to treat acute and mixed mania associated with bipolar I disorderAteeq Ahmad, Saifuddin Sheikh, Mujtaba Ali Khan, et al.
Discover Oncology|June 21, 2026
Bevacizumab added to conventional induction chemotherapy for children with high risk neuroblastoma (BRAVEN trial)Jagdish Prasad Meena, Debasish Sahoo, Harshita Makkar, et al.
Nano Letters|November 9, 2020
Modulation Doping via a Two-Dimensional Atomic Crystalline AcceptorYiping Wang, Jesse Balgley, Eli Gerber, et al.
Journal of Medicinal Chemistry|February 28, 2015
The discovery of Polo-like kinase 4 inhibitors: identification of (1R,2S).2-(3-((E).4-(((cis).2,6-dimethylmorpholino)methyl)styryl). 1H.indazol-6-yl)-5'-methoxyspiro[cyclopropane-1,3'-indolin]-2'-one (CFI-400945) as a potent, orally active antitumor agentPeter B Sampson, Yong Liu, Bryan Forrest, et al.
Pageof 88